Lupin launches Mycophenolic Acid Delayed-Release Tablets USP
Lupin has launched Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg. The company’s alliance partner Concord Biotech (Concord) had received an approval from the United States Food and Drug Administration (U.S. FDA) earlier. Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg, is the generic equivalent of Myfortic Delayed-Release Tablets, 180 mg … Read more